# OnCo record paper-esfahani-epic-seq-nat-biotechnol-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-esfahani-epic-seq-nat-biotechnol-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-esfahani-epic-seq-nat-biotechnol-2022" ;
  schema:name "Inferring gene expression from cell-free DNA fragmentation profiles"@en ;
  schema:description "How DNA fragments in blood are cut at the start of each gene predicted how active that gene was, enough to tell lung and lymphoma subtypes apart."@en ;
  schema:url <https://onco.cc/key-papers/paper-esfahani-epic-seq-nat-biotechnol-2022/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41587-022-01222-4>, <https://pubmed.ncbi.nlm.nih.gov/35361996/> ;
  schema:sameAs <https://doi.org/10.1038/s41587-022-01222-4> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Esfahani MS, Hamilton EG, Mehrmohamadi M, et al." ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/epic-seq/>, <https://onco.cc/technologies/fragmentomics/> ;
  onco:terms <https://onco.cc/terms/cfdna/>, <https://onco.cc/terms/ctdna/> ;
  onco:journals <https://onco.cc/journals/nature-biotechnology/> .